DeviceClearance

K231306

Substantially Equivalent

cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 Systems

Applicant
Roche Molecular Systems, Inc.
Product code
QQX
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Pleasanton, CA, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.